Infertility Treatment Devices Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 2.09 Billion |
| Market Size (2029) | USD 2.77 Billion |
| CAGR (2024 - 2029) | 5.78 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Infertility Treatment Devices Market Analysis
The Infertility Treatment Devices Market size is estimated at USD 2.09 billion in 2024, and is expected to reach USD 2.77 billion by 2029, growing at a CAGR of 5.78% during the forecast period (2024-2029).
COVID had a significant impact on the studied market. Various studies and articles have been published on the impact of COVID on in vitro fertilization (IVF). For instance, according to a research report published by PubMed Central in February 2021, SARS-CoV-2 is alleged to interfere with ART operations and disrupt female fertility via controlling ACE2. Consequently, it was anticipated that the pandemic would have an impact on market growth; however, with the decline in COVID-19 cases and widespread vaccination, it is anticipated that the studied market will once again reach its full potential over the forecast period.
The major factors attributing to the growth of the infertility treatment devices market are significant changes in lifestyle which contributed to the rise in infertility and the prevalence of conditions such as Polycystic Ovary Syndrome (PCOS). Also, a constant increase in the incidence of infertility in both sexes is projected to drive the market.
For instance, according to the data published by PubMed Central in June 2022, it was reported that South Korea showed the greatest decline in the fertility rate among the entire OECD countries over the last 30 years. The article also stated that the Korean government recognized the importance of healthy pregnancy and childbirth under these circumstances and implemented policies to raise the low fertility rate and support childbirth at advanced maternal by implementing 'The Fourth Basic Plan on Low Fertility and Aging Society' in 2021. Hence, a low fertility rate would increase the demand for in vitro fertilization and will increase market growth.
Furthermore, various development by market players and research institutes around the world are also contributing to the growth of the market. For instance, in March 2022, a few researchers from the Florida Atlantic University's College of Engineering and Computer Science developed a microfluidic chip-based device for sperm sorting that is fast, inexpensive, easy to operate, and efficiently isolates healthy sperm directly from semen. It effortlessly collects sorted sperm cells from the collecting chamber while minimizing contamination by deformed or dead sperm cells.
Thus, the abovementioned factors such as various development by market players and research institutes and low fertility rate are expected to increase market growth. However, the lack of availability to people due to the higher cost of IVF procedures and the possible risk of the baby being born with birth defects, risks of infections, and unfavorable scarring are expected to hinder the market growth.
Infertility Treatment Devices Market Trends
Fertility Clinics Segment is Expected to Hold a Significant Market Share Over the Forecast Period
Fertility clinics are specialty clinics that help people with their reproductive issues. Factors such as increasing the success rate of infertility treatment procedures, product launches, and opening of new facilities are expected to increase market growth. Due to the high procedure success rate and ongoing improvement, the studied segment is anticipated to experience growth.
For instance, according to an article published by Outlook India in July 2021, between 2,00,000 - 2,50,000 IVF procedures are performed in India each year, and the fertility market may experience 20% compound annual growth over the past five years. In-vitro fertilization is therefore anticipated to experience significant expansion during the predicted period. Moreover, the declining fertility rate is also a major factor that will lead to the growth of the segment.
Similarly, product launches are expected to increase segment growth as advanced products available in fertility clinics are expected to increase the footfall in the facility. In May 2022, Cook Medical launched the next-generation MINC+ benchtop incubator in the United States and Canada. The latest version of MINC incorporates the DishTrace platform, which combines capabilities for a variety of dish-data management tools through the touchscreen interface and a PC software program. With DishTrace, users may monitor up to 50 MINC+ incubators, follow culture dishes as they are checked in and out of the incubator, access, and log information through the system's touchscreen, and generate and view graphical histories and reports of MINC+ activities.
Moreover, the launch of fertility clinics is another factor in the growth of the market. For instance, in September 2021, Sakra World Hospital began offering infertility treatments, creating personalized treatment regimens for each patient. Such factors would spur market expansion in the near future.
Thus, the abovementioned factors such as the increasing success rates of infertility treatment procedures, declining fertility rate, and increasing product and fertility clinic launches are expected to increase the segment growth.
North America is Expected to Hold a Significant Share of the Market Over the Forecast Period
The North American region is expected to hold a significant market share in the studied market due to the increasing infertility rate and the need for external support in the region. For instance, according to the data published by CDC in March 2022, it is estimated that in the United States, among heterosexual women aged 15 to 49 years with no prior births, about 1 in 5 (19%) are unable to get pregnant after one year of trying (infertility). Also, about 1 in 4 (26%) women in this group have difficulty getting pregnant or carrying a pregnancy to term. As a result, the market will continue to expand favorably.
The low fertility rate in Canada is also a major factor driving the growth of the market in the region. For instance, according to the data updated by Statistics Canada in September 2022, the fertility rate in Canada declined drastically during the last 5 years, and it stood at 1.43 children per woman in 2021 which is way below the standard of 2.1 children per woman.
Awareness programs in the region are another factor in market growth. For instance, in June 2022, Organon Canada, a subsidiary of Organon, a global women's healthcare company, highlighted the importance of access to reproductive healthcare through listening to and empowering aspiring parents during World Infertility Awareness Month. The company aims to acknowledge and bring light to the barriers to fertility and help break down barriers to fertility.
Similarly, in April 2022, Inception Fertility initiated "The Faces of Fertility," a campaign to highlight the multidisciplinary team of specialists within Inception's clinical network who use education, science and technology, lab skills, and a compassionate approach to providing exceptional care throughout each patient's journey, in honor of National Infertility Awareness Week.
Thus, the abovementioned factors such as low fertility rate and increasing awareness programs about infertility are expected to increase the market growth.
Infertility Treatment Devices Industry Overview
The infertility treatment devices market is moderately competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions with other companies to consolidate their market positions across the globe and while others are distributing products. Some of the major players in the market are CooperSurgical Inc, Hamilton Thorne Inc, Dxnow (ZyMōt Fertility, Inc.), Cook Medical Inc, and Vitrolife among others.
Infertility Treatment Devices Market Leaders
-
CooperSurgical Inc
-
Hamilton Thorne Inc
-
Cook Medical Inc
-
Vitrolife
-
Dxnow (ZyMōt Fertility, Inc.)
*Disclaimer: Major Players sorted in no particular order
Infertility Treatment Devices Market News
- In September 2022, US Fertility launched the US Fertility Innovation Fund. The Innovation Fund will find, assess, and fund early-stage businesses that have the potential to influence the fertility industry's future and enhance patient care access and quality.
- In July 2022, Cellink, partnered with Spermosens, Malmö University, and Saint Louis University (SLU) to develop a diagnostic device to identify male infertility.
Infertility Treatment Devices Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Infertility and Prevalence of Conditions Such as Polycystic Ovary Syndrome (PCOS)
4.2.2 Increased Incidences of Infertility In Both Sexes
4.3 Market Restraints
4.3.1 Lack of Availability to People Due to Higher Cost of IVF Procedures
4.3.2 Possible Risk of Baby Being Born with Birth Defects, Risks of Infections and Unfavorable Scarring
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Type
5.1.1 Sperm Separation Devices
5.1.2 Ovum Aspiration Pumps
5.1.3 Sperm Analyzer Systems
5.1.4 Micromanipulator Systems
5.1.5 Incubators
5.1.6 Cryosystems
5.1.7 Imaging Systems
5.1.8 Microscopes
5.1.9 Others
5.2 By End-user
5.2.1 Fertility Clinics
5.2.2 Hospitals & Other Healthcare Facilities
5.2.3 Clinical Research Institutes
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 AB Scientific Ltd
6.1.2 Cook Medical Inc
6.1.3 CooperSurgical Inc
6.1.4 Dxnow (ZyMōt Fertility, Inc.)
6.1.5 Eppendorf Ag
6.1.6 Esco Micro Pte Ltd
6.1.7 Hamilton Thorne Inc
6.1.8 Ivftech Aps
6.1.9 MedGyn Products
6.1.10 Merck KgaA
6.1.11 Rocket Medical Plc
6.1.12 Vitrolife
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Infertility Treatment Devices Industry Segmentation
As per the scope of the report, infertility treatment devices are used in assisted reproductive treatments (ARTs) such as IVFs, imaging systems, and other techniques employed in the several options for patient treatment depending on the causes of infertility. Healthcare facilities specializing in ART treatments require a license from the respective authorities present in the country. The Infertility Treatment Devices Market Is Segmented By Type (Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Cryosystems, Imaging Systems, Microscopes, and Others), End User (Fertility Clinics, Hospitals & Other Healthcare Facilities, and Clinical Research Institutes), and Geography (North America, Europe, Asia-Pacific, Middle East And Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across the major regions globally. The report offers the values (USD million) for the above segments.
| By Type | |
| Sperm Separation Devices | |
| Ovum Aspiration Pumps | |
| Sperm Analyzer Systems | |
| Micromanipulator Systems | |
| Incubators | |
| Cryosystems | |
| Imaging Systems | |
| Microscopes | |
| Others |
| By End-user | |
| Fertility Clinics | |
| Hospitals & Other Healthcare Facilities | |
| Clinical Research Institutes |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Infertility Treatment Devices Market Research FAQs
How big is the Infertility Treatment Devices Market?
The Infertility Treatment Devices Market size is expected to reach USD 2.09 billion in 2024 and grow at a CAGR of 5.78% to reach USD 2.77 billion by 2029.
What is the current Infertility Treatment Devices Market size?
In 2024, the Infertility Treatment Devices Market size is expected to reach USD 2.09 billion.
Who are the key players in Infertility Treatment Devices Market?
CooperSurgical Inc, Hamilton Thorne Inc, Cook Medical Inc, Vitrolife and Dxnow (ZyMōt Fertility, Inc.) are the major companies operating in the Infertility Treatment Devices Market.
Which is the fastest growing region in Infertility Treatment Devices Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Infertility Treatment Devices Market?
In 2024, the North America accounts for the largest market share in Infertility Treatment Devices Market.
What years does this Infertility Treatment Devices Market cover, and what was the market size in 2023?
In 2023, the Infertility Treatment Devices Market size was estimated at USD 1.97 billion. The report covers the Infertility Treatment Devices Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Infertility Treatment Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Infertility Treatment Devices Industry Report
Statistics for the 2024 Infertility Treatment Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Infertility Treatment Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
Infertility Treatment Devices Market Report Snapshots
